Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study
Mycoses · 2025
DOI: 10.1111/myc.70096 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mycoses, 2025. Verfasst von Wdson Luis Lima Kruschewsky und 7 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases and Tropical Medicine Department, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. Hauptthemen laut MEDLINE: Paracoccidioidomycosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Background
Small studies have used various serological methods to evaluate the response to paracoccidioidomycosis (PCM) treatment, with limited use of counterimmunoelectrophoresis (CIE). This study assessed CIE titres during and after PCM therapy and their prognostic value for serological negativity.
Methods
In this retrospective study, we reviewed medical records of patients with positive serology in proven or probable PCM from 2006 to 2021 at University of São Paulo. We performed multivariate logistic regression to identify independent variables associated with CIE titre negativity.
Results
This study included 144 participants, totalling 979 serology samples analysed, with a predominance of middle‐aged adults (median age 50 years), males ( n = 112, 78%) and chronic form ( n = 112, 78%). Trimethoprim‐sulfamethoxazole ( n = 79, 55%) and itraconazole ( n = 55, 38%) were the drugs most commonly used. The median treatment time was 24 months (IQR 16–37). Median initial CIE titre was 1:32 (IQR 1:16–1:128). Thirty‐seven patients (26%) had a negative CIE titre, and 105 patients (73%) had CIE titres ≤ 1:4 at the last medical appointment. In multivariate analysis, only positive direct microscopy examination (OR 0.32, p = 0.043) was an independent factor related to non‐negativity serology. The time to negativity was shorter in female sex and negative microscopy.
Conclusion
The serology using CIE presented a strong association with clinical response, making it a valuable method for monitoring patients with PCM. Most patients achieved CIE titres ≤ 1:4 during antifungal therapy, which was strongly associated with a successful clinical response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases and Tropical Medicine Department, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
- Laboratory of Medical Mycology-LIM53, Instituto de Medicina Tropical, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
- Instituto do Câncer do Estado de São Paulo, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
ORCID-Profile: Wdson Luis Lima Kruschewsky, Gil Benard, Vítor Falcão de Oliveira
Zitieren
APA
Kruschewsky, W. L. L., Costa, A. H. R., Taborda, M., Vidal, M. S. M., Magri, A. S. G. K., Benard, G., de Oliveira, V. F., & Magri, M. M. C. (2025). Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study. Mycoses. https://doi.org/10.1111/myc.70096
Vancouver
Kruschewsky WLL, Costa AHR, Taborda M, Vidal MSM, Magri ASGK, Benard G, et al. Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study. Mycoses. 2025. doi:10.1111/myc.70096
BibTeX
@article{Kruschewsky2025,
author = {Kruschewsky, Wdson Luis Lima and Costa, Alice Heck Rodrigues and Taborda, Mariane and Vidal, Mônica Scarpelli Martinelli and Magri, Adriana Satie Gonçalves Kono and Benard, Gil and de Oliveira, Vítor Falcão and Magri, Marcello Mihailenko Chaves},
title = {Serological Response and Associated Prognostic Factors in Paracoccidioidomycosis: A 15‐Year Retrospective Study},
journal = {Mycoses},
year = {2025},
doi = {10.1111/myc.70096}
}
EUVIMED